Survival trends of oligodendroglial tumor patients and associated clinical practice patterns: a SEER-based analysis
- PMID: 28439777
- DOI: 10.1007/s11060-017-2430-z
Survival trends of oligodendroglial tumor patients and associated clinical practice patterns: a SEER-based analysis
Abstract
There is limited information on the management strategies and survival trends for oligodendroglioma patients. Here we used the Surveillance, Epidemiology and End Results (SEER, 1999-2012) database to analyze the historical trends of oligodendroglioma patient survival and correlate these trends to evolving clinical practice of radiation therapy (RT) use and surgical practice of gross total resection (GTR). We identified 2689 World Health Organization (WHO) grade II oligodendroglioma (abbreviated as O2) and 1191 WHO grade III oligodendroglioma (abbreviated as O3). Time-trend analyses were performed for overall survival, radiation treatment (RT) use, and extent of surgical resection (EOR). In multivariable Cox models that accounted for age, race, sex, tumor size, tumor location, EOR, and RT status, the hazard of dying from O3 has significantly decreased over the study period (p < 0.01), while the hazard of dying from O2 has remained largely unchanged. A search of the published literature revealed articles reporting results largely supportive of these observations. The pattern of surgical practice and RT for O3 patients remained unchanged throughout the study period, suggesting that the survival improvement may be related to evolving patterns of medical management. Results from the SEER database indicate significant gains have been made in survival for O3 patients between 1999 and 2012. Such gains were not observed for O2 patients during this study period.
Keywords: Oligodendroglioma; Practice pattern; SEER database; Survival; Trends.
Similar articles
-
Oligodendroglioma resection: a Surveillance, Epidemiology, and End Results (SEER) analysis.J Neurosurg. 2018 Apr;128(4):1076-1083. doi: 10.3171/2016.11.JNS161974. Epub 2017 May 12. J Neurosurg. 2018. PMID: 28498059
-
Effect of Gross Total Resection in World Health Organization Grade II Astrocytomas: SEER-Based Survival Analysis.World Neurosurg. 2017 Jul;103:741-747. doi: 10.1016/j.wneu.2017.03.140. Epub 2017 Apr 16. World Neurosurg. 2017. PMID: 28419878
-
Management and Survival Patterns of Patients with Gliomatosis Cerebri: A SEER-Based Analysis.World Neurosurg. 2017 Jul;103:186-193. doi: 10.1016/j.wneu.2017.03.103. Epub 2017 Mar 30. World Neurosurg. 2017. PMID: 28366748
-
Predictors of clinical outcome in pediatric oligodendroglioma: meta-analysis of individual patient data and multiple imputation.J Neurosurg Pediatr. 2018 Feb;21(2):153-163. doi: 10.3171/2017.7.PEDS17133. Epub 2017 Dec 1. J Neurosurg Pediatr. 2018. PMID: 29192869 Review.
-
An update on oligodendroglial neoplasms.Curr Opin Neurol. 2005 Dec;18(6):639-44. doi: 10.1097/01.wco.0000189877.31637.74. Curr Opin Neurol. 2005. PMID: 16280674 Review.
Cited by
-
Machine learning based survival prediction in Glioma using large-scale registry data.Health Informatics J. 2022 Oct-Dec;28(4):14604582221135427. doi: 10.1177/14604582221135427. Health Informatics J. 2022. PMID: 36264067 Free PMC article.
-
Extent of resection and survival for oligodendroglioma: a U.S. population-based study.J Neurooncol. 2019 Sep;144(3):591-601. doi: 10.1007/s11060-019-03261-5. Epub 2019 Aug 12. J Neurooncol. 2019. PMID: 31407129
-
Suggestions for Escaping the Dark Ages for Pediatric Diffuse Intrinsic Pontine Glioma Treated with Radiotherapy: Analysis of Prognostic Factors from the National Multicenter Study.Cancer Res Treat. 2023 Jan;55(1):41-49. doi: 10.4143/crt.2021.1514. Epub 2022 Mar 4. Cancer Res Treat. 2023. PMID: 35255651 Free PMC article.
-
A Population-Based Study of Treatment and Survival in Older Glioma Patients.JNCI Cancer Spectr. 2022 Jan 5;6(1):pkac010. doi: 10.1093/jncics/pkac010. JNCI Cancer Spectr. 2022. PMID: 35699501 Free PMC article.
-
Moving from clinician-defined to patient-reported outcome measures for survivors of high-grade glioma.Patient Relat Outcome Meas. 2019 Aug 23;10:267-276. doi: 10.2147/PROM.S179313. eCollection 2019. Patient Relat Outcome Meas. 2019. PMID: 31692481 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical